Bioventus (BVS) Change in Working Capital (2020 - 2022)
Bioventus' (BVS) quarterly Change in Working Capital came in at $1.1 million in Q2 2022, down 87.62% YoY from $9.2 million in Q2 2021, and up 59.27% on a QoQ basis from $712000.0 in Q4 2021.
Bioventus (BVS) Change in Working Capital (2020 - 2022) Analysis & Trends
Bioventus (BVS) has 3 years of Change in Working Capital data on file, last reported at $1.1 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 2, 2022 | 1.13 Mn |
| Apr 2, 2022 | 1.13 Mn |
| Oct 2, 2021 | 712,000.00 |
| Oct 2, 2021 | 712,000.00 |
| Jul 3, 2021 | 3.85 Mn |
| Jul 3, 2021 | 3.85 Mn |
| Apr 3, 2021 | 9.16 Mn |
| Apr 3, 2021 | 9.16 Mn |
| Sep 26, 2020 | -2.80 Mn |
| Sep 26, 2020 | -2.80 Mn |
| Jun 27, 2020 | 1.24 Mn |
| Jun 27, 2020 | 1.24 Mn |
| Mar 28, 2020 | -369,000.00 |
| Mar 28, 2020 | -369,000.00 |